Tamsulosin Hydrochloride
Product Images NDC 53217-159

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 53217-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ab8b786d-figure-01 (Tamsulosin HCl 1)

Chemical structure of tamsulosin hydrochloride showing its molecular connectivity including aromatic rings, methoxy groups, and hydrochloride salt component.*

FDA Label Image

1 (Tamsulosin HCl 2)

A line graph displaying plasma concentration (ng/mL) of tamsulosin hydrochloride over time (hours) comparing fasted and fed states. The graph shows two curves with concentration peaking earlier and higher in the fasted state than in the fed state, then gradually declining over 36 hours.*

FDA Label Image

Ab8b786d-figure-03 (Tamsulosin HCl 3)

Line graph showing mean change over a 13-week treatment duration comparing Tamsulosin hydrochloride 0.8 mg and 0.4 mg doses versus placebo. The x-axis represents weeks of treatment, and the y-axis shows mean change. The graph indicates greater mean change with higher doses compared to placebo over time.*

FDA Label Image

Ab8b786d-figure-04 (Tamsulosin HCl 4)

A line graph depicting mean change over duration of treatment in weeks for Tamsulosin hydrochloride at 0.8 mg, 0.4 mg, and placebo groups. The x-axis represents treatment duration up to 13 weeks and the y-axis shows mean change values. Data points display a clearer decrease for both Tamsulosin doses compared to placebo over time.*

FDA Label Image

Ab8b786d-figure-05 (Tamsulosin HCl 5)

A line graph depicting the mean change in urinary flow rate (mL/sec) over the duration of treatment in weeks for Tamsulosin hydrochloride at 0.4 mg and 0.8 mg doses compared to placebo. The graph shows treatment groups labeled with distinct symbols and sample sizes for each time point from baseline to 13 weeks and LOCF (last observation carried forward).*

FDA Label Image

Ab8b786d-figure-06 (Tamsulosin HCl 6)

A line graph depicting mean change in mL/sec over duration of treatment in weeks for Tamsulosin hydrochloride at 0.8 mg and 0.4 mg doses compared to placebo. The x-axis shows weeks (0 to 13) and the y-axis shows mean change from 0 to 3. Three treatment groups are represented with distinct markers and line styles. Sample sizes at various weeks are indicated along the x-axis.*

FDA Label Image

Image Description (Tamsulosin HCl 7)

Packaging label for Tamsulosin hydrochloride 0.4 mg capsules by Aidarex Pharmaceuticals LLC. The label indicates 30 capsules per container, generic for Flomax, with NDC 53217-0159-30. Manufacturer is Rottendorf Pharma GmbH Germany. The capsule is described as green and orange with black bands, oblong with a 'TSL 0.4' imprint on one side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.